arrow
A

Anna Vähärautio

university of helsinki
H指数:20
被引数:3,027

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Drug target proteome profiling identifies HES1-driven mitotic catastrophe in ovarian serous carcinoma

药物靶点蛋白质组学分析鉴定了HES1驱动的有丝分裂灾难在卵巢浆液性癌中的存在

2025-11-060
OAAI
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer

多组学分析揭示了干扰素通路衰减是化疗抵抗性卵巢癌的驱动因素。

2025-08-290
OAAI
Transgelin 2 guards T cell lipid metabolism and antitumour function

Transgelin 2保护T细胞脂质代谢和抗肿瘤功能

Nature
IF48.5
2024-10-230
PRE
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones

单细胞转录组鉴定针对癌症克隆的选择性共抑制的患者定制疗法

2024-10-030
OAAI
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
2024-07-172
OA
Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer
2024-03-040
PRE
Tracing back primed resistance in cancer via sister cells

通过姐妹细胞追溯癌症中引发的耐药性

2024-02-072
OAAI
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
2023-06-0128
OAAI
A platform utilizing high-grade serous ovarian cancer organoids for prospective patient stratification in functional precision medicine
2023-04-040
PRE